In Vivo is part of Pharma Intelligence UK Limited
This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Majority shareholder E. Merck OHG and other existing investors purchased 13.3mm new shares of Merck KGAA for €78 ($101) per share (an 11% discount), providing proceeds of €1.03bn to the company. The capital increase was pursued in part to finance Merck's recent acquisition of Serono.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?